About Tissue Heart Valves
Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues. Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.
Technavios analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavios report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Edwards Lifesciences
LivaNova
Medtronic
St. Jude Medical
Other prominent vendors
Braile Biomédica
CryoLife
Labcor Laboratórios
Market driver
Demand for stentless tissue valves
For a full, detailed list, view our report
Market challenge
Lack of skilled personnel
For a full, detailed list, view our report
Market trend
Increase in M&A
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Cost analysis
Cost analysis of valve replacement procedures
PART 07: Market segmentation by product
PART 08: Geographical segmentation
Tissue heart valves market in Americas
Tissue heart valves market in EMEA
Tissue heart valves market in APAC
PART 09: Market drivers
Prevalence of heart valve diseases
Demand for stentless tissue valves
Implementation of MI procedures
Rise in geriatric population
PART 10: Impact of drivers
PART 11: Market challenges
Use of alternative products
Risk of potential complications
Lack of skilled personnel
Stringent regulatory framework
PART 12: Impact of drivers and challenges
PART 13: Market trends
Demand for tissue heart valves in APAC
Preference among geriatric population
Increase in M&A
PART 14: Vendor landscape
Competitive scenario
Market share analysis 2015
Edwards Lifesciences
LivaNova
Medtronic
St. Jude Medical
Other prominent vendors
PART 15: Appendix
List of abbreviations
PART 16: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global tissue heart valves market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
Exhibit 05: Global tissue heart valves market segmentation by product
Exhibit 06: Global tissue heart valves market segmentation by product 2015
Exhibit 07: Global tissue heart valves market segmentation by geography 2015
Exhibit 08: Global tissue heart valves market segmentation by geography 2020
Exhibit 09: Global tissue heart valves market segmentation by geography 2015-2020
Exhibit 10: Tissue heart valves market in Americas 2015-2020 ($ millions)
Exhibit 11: Tissue heart valves market in US 2015-2020 ($ millions)
Exhibit 12: Tissue heart valves market in EMEA 2015-2020 ($ millions)
Exhibit 13: Tissue heart valves market in APAC 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Cost comparison of heart valve replacement procedures
Exhibit 17: Ranking of top vendors 2015
Exhibit 18: Edwards Lifesciences: Key takeaways
Exhibit 19: LivaNova: Key takeaways
Exhibit 20: Medtronic: Key product offerings
Exhibit 21: Medtronic: Key takeaways
Exhibit 22: St. Jude Medical: Key takeaways
